CME Group (NASDAQ:CME) Downgraded to Hold at BidaskClub

BidaskClub cut shares of CME Group (NASDAQ:CME) from a buy rating to a hold rating in a report published on Friday, BidAskClub reports.

Other analysts also recently issued research reports about the company. Wells Fargo & Co raised their price objective on CME Group from $176.00 to $200.00 and gave the stock a market perform rating in a research note on Wednesday, July 3rd. Deutsche Bank raised their price objective on CME Group from $224.00 to $240.00 and gave the stock a buy rating in a research note on Friday, August 9th. Berenberg Bank downgraded CME Group from a buy rating to a hold rating and dropped their price objective for the stock from $236.00 to $227.00 in a research note on Thursday, September 19th. Oppenheimer started coverage on CME Group in a research note on Monday, September 16th. They set an outperform rating and a $234.00 price objective on the stock. Finally, ValuEngine downgraded CME Group from a buy rating to a hold rating in a research note on Wednesday, October 2nd. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the stock. The company has an average rating of Hold and an average price target of $200.43.

CME stock opened at $213.17 on Friday. The business’s fifty day moving average is $213.58 and its 200-day moving average is $198.37. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. The company has a market cap of $76.28 billion, a P/E ratio of 32.27, a price-to-earnings-growth ratio of 4.51 and a beta of 0.20. CME Group has a twelve month low of $161.05 and a twelve month high of $224.91.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.75 by $0.01. The company had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The firm’s quarterly revenue was up 20.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.74 EPS. Research analysts anticipate that CME Group will post 6.79 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th were paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.41%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s payout ratio is presently 43.99%.

In other CME Group news, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $217.62, for a total transaction of $544,050.00. Following the completion of the transaction, the chief financial officer now owns 30,354 shares in the company, valued at approximately $6,605,637.48. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Sean Tully sold 7,200 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $223.13, for a total value of $1,606,536.00. Following the transaction, the insider now owns 19,923 shares of the company’s stock, valued at approximately $4,445,418.99. The disclosure for this sale can be found here. In the last quarter, insiders have sold 57,126 shares of company stock valued at $11,752,684. Corporate insiders own 1.20% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in the business. Avitas Wealth Management LLC increased its holdings in CME Group by 1.6% during the 3rd quarter. Avitas Wealth Management LLC now owns 22,692 shares of the financial services provider’s stock worth $4,796,000 after purchasing an additional 354 shares in the last quarter. Coastline Trust Co bought a new position in shares of CME Group in the 3rd quarter valued at about $596,000. Whittier Trust Co. of Nevada Inc. grew its holdings in shares of CME Group by 4.9% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,218 shares of the financial services provider’s stock valued at $258,000 after acquiring an additional 57 shares in the last quarter. Tuttle Tactical Management bought a new position in shares of CME Group in the 3rd quarter valued at about $450,000. Finally, Moller Financial Services grew its holdings in shares of CME Group by 71.7% in the 3rd quarter. Moller Financial Services now owns 3,006 shares of the financial services provider’s stock valued at $635,000 after acquiring an additional 1,255 shares in the last quarter. Hedge funds and other institutional investors own 84.90% of the company’s stock.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Story: If I purchase shares through a brokerage account, am I the holder of record?

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.